Cutaneous Squamous Cell Carcinoma of the Head and Neck Clinical Trial
Official title:
Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck
In this prospective cohort study, investigators will conduct ultrasound surveillance of the nodal basins of patients with head and neck cutaneous squamous cell carcinoma (cSCC) whose tumors are considered high risk and staged by the Brigham and Women's Hospital (BWH) tumor staging system. The study will enroll patients with tumors staged T2a and who are also immunosuppressed (from solid organ transplant, hematologic malignancy or autoimmune disease), T2b (sentinel lymph node negative), and T3 (sentinel lymph node negative). After two years of surveillance, outcomes regarding local recurrence, nodal metastasis, disease specific death, and overall survival will be compared with historical controls with the overall hypothesis that ultrasound surveillance will detect subclinical disease earlier and help improve outcomes.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06046625 -
Needs and Preferences of Patients With Head-neck Cutaneous SCC
|
||
| Recruiting |
NCT05878288 -
Deep sequencIng in Cutaneous Squamous CEll caRciNomas
|
Phase 2 | |
| Active, not recruiting |
NCT03491176 -
Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
|
N/A | |
| Recruiting |
NCT05025813 -
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
|
Phase 2 | |
| Terminated |
NCT04242173 -
Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC
|
Phase 2 | |
| Recruiting |
NCT05482880 -
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
|
||
| Recruiting |
NCT05075980 -
HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers
|
Phase 2 |